Perinatal and childhood outcomes of children born to female cancer survivors in South Korea

• Published in: Scientific reports Vol. 14; no. 1; p. 2418
• Main Authors: Jin, Ju Hyun, Youk, Tae Mi, Yun, Jisun, Heo, Ja Yoon
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 29.01.2024; Nature Publishing Group UK; Nature Portfolio
• Subjects: Birth Weight; Cancer; Cancer Survivors; Child; Children; Chromosome aberrations; Death; Developmental disabilities; Epilepsy; Female; Females; Gestational Age; Hearing loss; Humans; Infant, Low Birth Weight; Infant, Newborn; Low birth weight; Mortality; Neonates; Neoplasms - epidemiology; Offspring; Population studies; Pregnancy; Premature birth; Premature Birth - epidemiology; Statistical analysis; South Korea
• DOI: 10.1038/s41598-024-53088-y
• ISSN: 2045-2322

Despite the increasing number of female cancer survivors, uncertainty remains regarding potential adverse health outcomes for their offspring. Comprehensive population-based studies would be invaluable for female cancer survivors in making decisions about their future. This study uses the National Health Information Database to investigate perinatal and long-term outcomes of offspring born to mothers with a history of cancer. In a South Korean cohort of 95,264 women aged 15-40 diagnosed with cancer between 2007 and 2010, we evaluated the outcomes of 15,221 children born to 11,092, cancer survivors. We selected 147,727 women without a history of cancer and 201,444 children as a control group. Our study found that children of female cancer survivors have a significantly higher odds ratio of primary outcomes including preterm birth, low birth weight, neonatal intensive care unit admission, and death. While there was no difference in the rate of death within 1 year of birth between the two groups, the total death rate during the follow-up period was significantly higher in children born to mothers with cancer. After adjusting for gestational age and birth weight, there was no statistically significant increased hazard ratio of secondary outcomes including cancer, chromosomal abnormalities, cerebral palsy, delayed development, epilepsy, language disorder, or hearing impairment.